DR. INFOvsOpenEvidenceUpdated 16 October 2026

OpenEvidence in Austria: is it available, and what do Austrian doctors use instead? (2026)

The best OpenEvidence alternative in Austria is DR. INFO: a clinical AI built in Europe and hosted in the EU that writes a cited answer in German from guidelines and literature, and can be used from Austria now that OpenEvidence has ended access from the EU. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, citing regulatory uncertainty around European AI rules, and access from Austrian and other European addresses has been blocked since [1][2]. There was never a German version: OpenEvidence answered in English from US-oriented sources. The 53,353 doctors that the Austrian Medical Chamber counted on 31 December 2025 [3] still have the familiar references: the Austria-Codex for the summaries of product characteristics [4] and the German-language S3 guidelines that Austrian societies co-author [5]. Both are documents to be read, not answers to a question about the patient in the Ordination or on the ward in front of you. On OpenAI's HealthBench Hard, DR. INFO scored 0.72 against OpenEvidence's 0.49 on the same 100 examples [6][7]. This page covers what happened, what remains in Austria, and how the options compare for practice, hospital and Turnus.

DR. INFO and OpenEvidence, side by side

Available in Austria

DR. INFO Yes, on the web and the iPhone app

OpenEvidence No, access from the EU ended 28 April 2026

Answers in German

DR. INFO Yes, in the language you ask in; German interface

OpenEvidence No, English only

How it answers

DR. INFO A written answer built from retrieved guidelines and literature, each statement cited

OpenEvidence A written answer with citations, US-oriented sources

Data hosting

DR. INFO European Union, under GDPR

OpenEvidence United States

Guideline sources

DR. INFO European and national guidelines, retrieved per question, including the German-language S3 guidelines with Austrian participation

OpenEvidence US-centred

Drug information

DR. INFO FDA and EMA authorised sources, EMA SmPC; the Austria-Codex remains the Austrian reference

OpenEvidence US sources

Documentation

DR. INFO Scribe with SOAP notes and discharge letters in the same product

OpenEvidence None

Regulatory status

DR. INFO CE marked medical device under EU MDR 2017/745, which applies directly in Austria

OpenEvidence Not CE marked

HealthBench Hard (same 100 examples)

DR. INFO 0.72

OpenEvidence 0.49

Cost

DR. INFO Free tier, paid plans

OpenEvidence Was free for verified clinicians

How DR. INFO compares with OpenEvidence

DR. INFO and OpenEvidence on HealthBench Hard

Rubric graded scores on difficult, open ended clinical conversations, from the same 100 example run. Higher is better.

0.250.500.751.000.72DR. INFO0.49OpenEvidence

Source: Ravichandran S, et al. OpenAI’s HealthBench in Action. arXiv:2509.02594.

Frequently asked questions

Is OpenEvidence available in Austria in 2026?
No. OpenEvidence terminated app access in the EU and the UK on 28 April 2026, and access from Austrian and other European addresses has been blocked since. The company cited regulatory uncertainty around European AI rules. No return date has been announced.
Is OpenEvidence blocked in Austria, or is it an outage?
It is a block, not an outage. Since 28 April 2026 OpenEvidence has refused access from the EU, and Austria is an EU member. Opening the site or the app from Vienna, Graz or Innsbruck returns no answer, whatever the device, account or network. Restarting does not help, because the service is deliberately unreachable from Europe.
Is there a German version of OpenEvidence?
No. OpenEvidence never answered in German or offered a German interface, and its sources were US-oriented. DR. INFO answers in the language you ask in, German included, and the product itself is available in German.
Does the OpenEvidence app still work in Austria?
No. The app can be installed, but sign-in and access from EU addresses have been blocked since April 2026, in the app and in the browser alike. DR. INFO works in the browser at app.drinfo.ai and on the iPhone app, from Austria without workarounds.
When will OpenEvidence come to Austria?
There is no date. The withdrawal was tied to European AI regulation, whose obligations for medical AI phase in through 2027, so a return would be a decision by the company rather than a technical fix. A clinician who needs a cited answer today is better off not waiting for it.
Why did OpenEvidence leave Europe?
OpenEvidence withdrew from the EU and the UK together, citing uncertainty about European AI regulation, including the EU AI Act. Commentary in the medical press has treated the move as a sign of the regulatory divide between US health AI and European rules [8].
What do Austrian doctors use instead of OpenEvidence?
Two kinds of tool. The Austrian references: the Austria-Codex with the summaries of product characteristics of every medicine authorised in Austria [4], the e-Medikation in ELGA for the patient's current medication [9], and the S3 guidelines in the AWMF register, many of which are written together with Austrian societies [5]. And DR. INFO, a European clinical AI that answers a clinical question with citations you can open, hosts data in the EU, and includes a scribe and discharge letter drafting.
Is DR. INFO the best OpenEvidence alternative for Austrian doctors?
For a clinician who wants what OpenEvidence did, a cited written answer to a clinical question, DR. INFO is the closest fit that can be used from Austria: it retrieves guidelines and literature for each question, cites every statement, hosts data in the EU, answers in German and scored 0.72 against OpenEvidence's 0.49 on HealthBench Hard.
How does DR. INFO cite its answers?
Each answer is written from documents retrieved for that question, and each statement carries a citation that opens the source: a guideline, a peer reviewed paper, or an FDA or EMA drug document. That makes the answer checkable in the way a colleague's summary is not. In a prospective pilot study published in Cureus in 2026, physicians using DR. INFO at the point of care rated that traceability as part of its value [10].
Does DR. INFO cover Austrian guidelines?
Austria has no central guideline register of its own like the AWMF. Many of the recommendations Austrian clinicians treat by are the German-language S3 guidelines that Austrian societies co-author, alongside European guidelines from the ESC, ESMO or KDIGO. DR. INFO retrieves these sources per question and answers in German; with the country set to Austria, national recommendations are preferred. Coverage is broad but not complete for any society; the source document is linked in every answer, and the current version remains authoritative.
Where is the data hosted, and what does that mean for an Austrian practice or hospital?
DR. INFO is hosted in the European Union under GDPR, which applies directly in Austria and is supplemented by the Datenschutzgesetz. Whether a tool may be used with identifiable patient data is still a decision for each Ordination, group practice and hospital, with medical confidentiality under the Ärztegesetz in mind. Asking a clinical question without patient identifiers does not transfer health data; for anything beyond that, the data protection officer is the right person to ask.
Is DR. INFO free for doctors in Austria?
There is a free tier for doctors, Turnusärzte and medical students, with paid plans for heavier use. It works in the browser at app.drinfo.ai and on the iPhone app, from Austria without restriction.
Does using DR. INFO count towards DFP credit?
No. DR. INFO is a working tool for daily practice, not an approved training activity. DFP points in Austria come only from activities approved by the Akademie der Ärzte and recorded on meindfp.at [11]. What DR. INFO contributes is the path to the guideline or the paper behind an answer; the reading and learning remain yours.
Is DR. INFO a certified medical device?
Yes. DR. INFO is CE marked under EU MDR 2017/745 [12], which applies directly in Austria with the Federal Office for Safety in Health Care as the competent authority. It is developed and operated by Synduct GmbH in Munich.

OpenEvidence is not coming to Austria on any announced date, there was never a German version, and the Austria-Codex was never an answer engine. For a clinician in practice, hospital or Turnus who wants a cited answer to a clinical question, DR. INFO is the tool to try first: built in Europe, hosted in the EU, in German, free to start, and scoring higher than OpenEvidence on the hardest public benchmark of clinical answers.

References

  1. 1.Breaking: OpenEvidence app access terminated in the UK and EU. Telehealth and Telecare Aware. 28 April 2026.
  2. 2.The US-based medical search engine OpenEvidence is down in Europe: a commentary on regulatory complexities. Intelligence-Based Medicine. 2026.
  3. 3.Österreichische Ärztekammer. Aktuelle Ärztestatistik: Trends, die in der Gesundheitspolitik bedacht werden sollten. Presseaussendung, 29. Juli 2026.
  4. 4.Österreichische Apotheker-Verlagsgesellschaft. Austria-Codex: Fachinformationen der in Österreich zugelassenen Arzneispezialitäten.
  5. 5.AWMF. Leitlinienregister: aktuelle Leitlinien der wissenschaftlichen medizinischen Fachgesellschaften.
  6. 6.Ravichandran S, Kumar S, Corga Da Silva R, Romano M, et al. OpenAI’s HealthBench in Action: Evaluating an LLM-Based Medical Assistant on Realistic Clinical Queries. arXiv:2509.02594. 2026.
  7. 7.Arora RK, Wei J, Soskin Hicks R, et al. HealthBench: Evaluating Large Language Models Toward Improved Human Health. OpenAI. 2025.
  8. 8.OpenEvidence exits Europe, highlighting divide in health AI rules. Telehealth.org. 2026.
  9. 9.ELGA GmbH. ELGA: die elektronische Gesundheitsakte in Österreich.
  10. 10.Corga Da Silva R, Romano M, Mendes T, et al. DR. INFO at the Point of Care: A Prospective Pilot Study of Physician-Perceived Value of an Agentic Artificial Intelligence Clinical Assistant. Cureus. 2026.
  11. 11.Österreichische Akademie der Ärzte. meindfp.at: das Diplom-Fortbildungs-Programm der Österreichischen Ärztekammer.
  12. 12.Regulation (EU) 2017/745 of the European Parliament and of the Council on medical devices (EU MDR). Official Journal of the European Union. 2017.